Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany

<p>Abstract</p> <p>Background</p> <p>In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic infl...

Full description

Bibliographic Details
Main Authors: Böhmer Merle M, Walter Dietmar, Falkenhorst Gerhard, Müters Stephan, Krause Gérard, Wichmann Ole
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Public Health
Subjects:
Online Access:http://www.biomedcentral.com/1471-2458/12/938
_version_ 1811249090055372800
author Böhmer Merle M
Walter Dietmar
Falkenhorst Gerhard
Müters Stephan
Krause Gérard
Wichmann Ole
author_facet Böhmer Merle M
Walter Dietmar
Falkenhorst Gerhard
Müters Stephan
Krause Gérard
Wichmann Ole
author_sort Böhmer Merle M
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic influenza A(H1N1)pdm09, which was controversially discussed in the public, was recommended for the whole population. The objectives of this study were to assess vaccination coverage for seasonal (seasons 2008/09-2010/11) and pandemic influenza (season 2009/10), to identify predictors of and barriers to pandemic vaccine uptake and whether the controversial discussions on pandemic vaccination has had a negative impact on seasonal influenza vaccine uptake in Germany.</p> <p>Methods</p> <p>We analysed data from the ‘German Health Update’ (GEDA10) telephone survey (n=22,050) and a smaller GEDA10-follow-up survey (n=2,493), which were both representative of the general population aged ≥18 years living in Germany.</p> <p>Results</p> <p>Overall only 8.8% of the adult population in Germany received a vaccination against pandemic influenza. High socioeconomic status, having received a seasonal influenza shot in the previous season, and belonging to a target group for seasonal influenza vaccination were independently associated with the uptake of pandemic vaccines. The main reasons for not receiving a pandemic vaccination were ‘fear of side effects’ and the opinion that ‘vaccination was not necessary’. Seasonal influenza vaccine uptake in the pre-pandemic season 2008/09 was 52.8% among persons aged ≥60 years; 30.5% among HCW, and 43.3% among chronically ill persons. A decrease in vaccination coverage was observed across all target groups in the first post-pandemic season 2010/11 (50.6%, 25.8%, and 41.0% vaccination coverage, respectively).</p> <p>Conclusions</p> <p>Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. In the upcoming years, the uptake of seasonal influenza vaccines should be carefully monitored in all target groups to identify if this trend continues and to guide public health authorities in developing more effective vaccination and communication strategies for seasonal influenza vaccination.</p>
first_indexed 2024-04-12T15:39:21Z
format Article
id doaj.art-cea94f75e1fd4dad97624529f68e3b75
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-04-12T15:39:21Z
publishDate 2012-10-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-cea94f75e1fd4dad97624529f68e3b752022-12-22T03:26:51ZengBMCBMC Public Health1471-24582012-10-0112193810.1186/1471-2458-12-938Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in GermanyBöhmer Merle MWalter DietmarFalkenhorst GerhardMüters StephanKrause GérardWichmann Ole<p>Abstract</p> <p>Background</p> <p>In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic influenza A(H1N1)pdm09, which was controversially discussed in the public, was recommended for the whole population. The objectives of this study were to assess vaccination coverage for seasonal (seasons 2008/09-2010/11) and pandemic influenza (season 2009/10), to identify predictors of and barriers to pandemic vaccine uptake and whether the controversial discussions on pandemic vaccination has had a negative impact on seasonal influenza vaccine uptake in Germany.</p> <p>Methods</p> <p>We analysed data from the ‘German Health Update’ (GEDA10) telephone survey (n=22,050) and a smaller GEDA10-follow-up survey (n=2,493), which were both representative of the general population aged ≥18 years living in Germany.</p> <p>Results</p> <p>Overall only 8.8% of the adult population in Germany received a vaccination against pandemic influenza. High socioeconomic status, having received a seasonal influenza shot in the previous season, and belonging to a target group for seasonal influenza vaccination were independently associated with the uptake of pandemic vaccines. The main reasons for not receiving a pandemic vaccination were ‘fear of side effects’ and the opinion that ‘vaccination was not necessary’. Seasonal influenza vaccine uptake in the pre-pandemic season 2008/09 was 52.8% among persons aged ≥60 years; 30.5% among HCW, and 43.3% among chronically ill persons. A decrease in vaccination coverage was observed across all target groups in the first post-pandemic season 2010/11 (50.6%, 25.8%, and 41.0% vaccination coverage, respectively).</p> <p>Conclusions</p> <p>Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. In the upcoming years, the uptake of seasonal influenza vaccines should be carefully monitored in all target groups to identify if this trend continues and to guide public health authorities in developing more effective vaccination and communication strategies for seasonal influenza vaccination.</p>http://www.biomedcentral.com/1471-2458/12/938VaccinationInfluenzaCoveragePandemicGermany
spellingShingle Böhmer Merle M
Walter Dietmar
Falkenhorst Gerhard
Müters Stephan
Krause Gérard
Wichmann Ole
Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
BMC Public Health
Vaccination
Influenza
Coverage
Pandemic
Germany
title Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
title_full Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
title_fullStr Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
title_full_unstemmed Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
title_short Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
title_sort barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post pandemic season in germany
topic Vaccination
Influenza
Coverage
Pandemic
Germany
url http://www.biomedcentral.com/1471-2458/12/938
work_keys_str_mv AT bohmermerlem barrierstopandemicinfluenzavaccinationanduptakeofseasonalinfluenzavaccineinthepostpandemicseasoningermany
AT walterdietmar barrierstopandemicinfluenzavaccinationanduptakeofseasonalinfluenzavaccineinthepostpandemicseasoningermany
AT falkenhorstgerhard barrierstopandemicinfluenzavaccinationanduptakeofseasonalinfluenzavaccineinthepostpandemicseasoningermany
AT mutersstephan barrierstopandemicinfluenzavaccinationanduptakeofseasonalinfluenzavaccineinthepostpandemicseasoningermany
AT krausegerard barrierstopandemicinfluenzavaccinationanduptakeofseasonalinfluenzavaccineinthepostpandemicseasoningermany
AT wichmannole barrierstopandemicinfluenzavaccinationanduptakeofseasonalinfluenzavaccineinthepostpandemicseasoningermany